EGF and cancer: In brief, these mechanisms include increased generation of ligands (e.g., epidermal growth factor, EGF) for growth factor receptors (GFRs), increased receptor signaling as a result of upregulated GFRs at the surface of cancer cells, receptor activation without the need for ligands (ligand-independent firing), and constitutive activation of the elements within signaling pathways.